Clinical protocols, member stories, and plain-language science from the Meto care team. We publish what we'd want to read if we were figuring this out for the first time
MOTS-c peptide metabolic health research is pointing to a mitochondrial-derived signal your body already produces — one that declines with age and worsens insulin resistance. This pillar guide explains how MOTS-c activates the AMPK pathway, what the human and animal evidence shows, which patients may benefit, and how to assess your metabolic baseline before exploring peptide therapy.
